glp 1 medication mounjaro FDA approves new version of diabetes drug to be sold for weight loss GLP-1 use tripled among non-diabetics,

Ready to start your weight loss journey with medication that actually works

The SGLT2 inhibitor empagliflozin ameliorates the inflammatory profile in type 2 diabetic patients and promotes an antioxidant response in leukocytes

Partly because they were slightly on the leaner side, and again, with the small numbers, I wouldnt be able to make a definite assessment on that, because I dont want to give the wrong impression

It works best when it is part of a thoughtful, individualized care plan guided by a qualified healthcare professional

doi: 10.3390/nu2030355 163

Palmer SC, Tendal B, Mustafa RA et al (2021) Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials